An AMCP Member Webinar.

Population health and managed care pharmacy are often discussed as separate concepts, yet much of today’s pharmacy work sits squarely at their intersection. This webinar is designed to introduce the basics, creating a shared foundation of language and understanding for professionals working across health systems, payers, pharmaceutical organizations, and related settings. Participants will explore how population health, value-based care, and managed care pharmacy overlap in practice—even when professionals don’t identify their work as managed care. By clarifying terminology and roles, this session helps attendees better understand where they fit within the broader healthcare ecosystem and how their work aligns with AMCP’s mission.

An AMCP Webinar, presented by Cencora. Open to healthcare decision-makers only.

Healthcare decision-makers play a critical role in shaping patient access and coverage decisions. This webinar explains how the Cencora team partners with healthcare decision-makers to gather perspectives through structured market research and what to expect if you choose to participate as a panel member.

We will cover the common research formats you may be invited to join (eg, surveys, in-depth interviews, advisory boards), the topics typically explored in market access research, and how participation fits into your schedule. You'll also get inside look at the participant experience, from registration and qualification to fair market value (FMV) determination, study invitations, scheduling, participation, and honoraria timelines.

A Pre-Approval Information Exchange (PIE) Webinar, presented by Beren Therapeutics P.B.C.

This webinar provides an overview of infantile onset Niemann Pick disease type C, a rare, autosomal recessive neurodegenerative disorder caused by impaired intracellular cholesterol trafficking that leads to progressive neurologic decline and premature death, and discusses emerging clinical evidence for adrabetadex, an investigational therapy designed to re establish cholesterol trafficking. Topics include disease burden, unmet need, clinical and safety results, and managed care implications.

This webinar is only offered to payers, formulary committees, or other similar entities responsible for the selection of drugs for coverage or reimbursement. In order to join this webinar, you must be registered as a user of FormularyDecisions.

This product is in the clinical evaluation stage and has not been approved for use by the FDA. The safety and efficacy of this product have not been established.

A Pre-Approval Information Exchange (PIE) Webinar, presented by Mineralys Therapeutics, Inc.

This Pre-Approval Information Exchange (PIE) webinar will review the burden, pathophysiology, and unmet need in uncontrolled and treatment-resistant hypertension, including the role of aldosterone. The session will also provide an overview of lorundrostat, an investigational aldosterone synthase inhibitor, including its mechanism of action and key clinical trial data to inform healthcare decision-making.

This webinar is only offered to payers, formulary committees, or other similar entities responsible for the selection of drugs for coverage or reimbursement. In order to join this webinar, you must be registered as a user of FormularyDecisions.

This product is in the clinical evaluation stage and has not been approved for use by the FDA. The safety and efficacy of this product have not been established.

An AMCP Market Insights Webinar.

This webinar will explore payer perspectives on hard-to-control hypertension, including ongoing unmet needs in blood pressure management, barriers to effective care, and the factors that influence current management strategies. Attendees will gain insight into payer decision-making priorities, evidence sources, and opportunities for managed care stakeholders to improve care delivery and patient outcomes.

A Science & Innovation Webinar, presented by Cytokinetics.

• Symptomatic obstructive hypertrophic cardiomyopathy (oHCM) is a chronic, progressive condition affecting 1:200 to 1:500 individuals in the US^1,2
• Despite available standard-of-care therapies, patients may experience impaired functional capacity and disease progression, driving the need for therapies that target the underlying oHCM pathophysiology rather than symptoms alone^2-4
• This webinar will be led by Rachel Lavelle, PharmD, who brings complementary clinical and managed care perspectives on oHCM, combining deep experience in cardiology care, guideline-directed therapy implementation, and value-focused cardiovascular outcomes

An AMCP Market Insights Webinar.

This webinar will explore payer perspectives on ESR1-Mutated advanced breast cancer. Attendees will gain insight into payer decision-making priorities, evidence sources, and opportunities for managed care stakeholders to improve care delivery and patient outcomes.